Netherlands Translational Research Center B.V.
NTRC focuses on the development of new drugs based on small chemical compounds ("small molecules"). NTRC is the first "small molecule" company that settles at the Life Sciences Park in Oss. Besides the innovative drug development on a large panel of human cancer cell lines, NTRC will set up a service of profiling drug candidates for other pharmaceutical companies at the Life Sciences Park.
For more information: www.ntrc.nl